AKT2 Antibody from ANTIBODIES-ONLINE GmbH

Search, find, compare suppliers for anti-AKT2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAKT2
CloneRB11384
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpurified
Size400 µL
Concentrationn/a
ApplicationsDot Blot
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRabbit anti-AKT2 monoclonal antibody, unconjugated
ImmunogenThis Phospho-AKT2-S474 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S474 of human AKT2.
Other NamesHIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA|PKB beta|RAC-PK-beta|RAC-beta serine hreonine-protein kinase|murine thymoma viral (v-akt) homolog-2|protein kinase Akt-2|protein kinase B beta|rac protein kinase beta|AKT serine/threonine kinase 2|AKT2|V-Akt Murine Thymoma Viral Oncogene Homolog 2|AKT2 kinase|RAC protein kinase beta RAC-PK beta|murine thymoma viral (v-akt) oncogene homolog 2|protein kinase B|beta|thymoma viral proto-oncogene 2|cb945|pkbss|v-akt2|RAC-beta serine hreonine-protein kinase-like|serine hreonine protein kinase|2410016A19Rik|AW554154|PKB|RAC-beta serine hreonine protein kinase|akt2-a|PKB beta-A|RAC-PK-beta-A|RAC-beta serine hreonine-protein kinase A|protein kinase Akt-2-A|beta-A|v-akt murine thymoma viral oncogene homolog 2 L homeolog|akt2.L|Serine/threonine-protein kinase akt-2|akt-2
Gene, Accession #Gene ID: 208
Catalog #ABIN389734
Price$429
Order / More InfoAKT2 Antibody from ANTIBODIES-ONLINE GmbH
Product Specific Referencesn/a
ANTIBODIES-ONLINE GmbH
ANTIBODIES-ONLINE GmbH
ANTIBODIES-ONLINE GmbH
Schloss-Rahe-Str. 15
52072 Aachen GERMANY
P: +49 (0)241 95 163 153
F: +49 (0)241 95 163 155

info@antibodies-online.com
Orders: orders@antibodies-online.com
Technical Support: support@antibodies-online.com

https://www.antibodies-online.com

Profile of ANTIBODIES-ONLINE GmbH
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.